Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Wockhardt divulges beta-lactamase inhibitors

Aug. 10, 2015

Keystone Nano awarded NIAID contract to develop RNAi therapeutic for influenza

Aug. 7, 2015

Apodemus AB patents antivirals

Aug. 7, 2015

GSK initiates first-in-human study of RSV vaccine GSK-3389245A

Aug. 7, 2015

3-V Biosciences describes fatty acid synthase inhibitors

Aug. 5, 2015

CSL completes acquisition of Novartis influenza vaccine business

Aug. 5, 2015

Cidara Therapeutics begins phase I study of CD-101 IV

Aug. 4, 2015

ADMA Biologics files BLA for immune globulin RI-002

Aug. 4, 2015

ContraVir Pharmaceuticals enrolls first patient in pivotal phase III trial of FV-100

Aug. 4, 2015

rVZV-ZEBOV Ebola vaccine up to 100% effective, interim results of West African trial indicate

Aug. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...